RB1 and neoplasm: The significantly distinct molecular components in MYCN tumors, such as upregulated translation processes or hypermethylated genes related to metabolism, cell cycle transition, or cilium assembly, may imply the presence of differential cellular and oncogenic dynamics unique to the MYCN-amplified RB1-proficient tumor subtype.